Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | LCK | P06239 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.53 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7822400 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL7075692 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL1114840 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL22552779 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL22552585 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL7083484 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL2498859 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL7080515 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL1271078 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT | |
| SCHEMBL1114783 | 1.00 | GPR84 (0.61) | GPR84FFAR1SPHK1ACE2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11112717-B2 | Electrostatic ink compositions and scratch-off structures | HP INDIGO B.V. (NL) | 2021-09-07 | — | — | US | claimed |
| EP-0802254-B1 | Refrigerator oil composition | IDEMITSU KOSAN CO (JP) | 2003-07-09 | — | — | EP | claimed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| EP-3681875-B1 | CYCLIC PEPTIDE ANTIBIOTICS | HOFFMANN LA ROCHE (CH) | 2026-01-14 | — | — | EP | disclosed |
| US-11279735-B2 | Cyclic peptide antibiotics | GENENTECH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-11279735-B2 | Cyclic peptide antibiotics | GENENTECH, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| CN-109476936-B | Electrostatic ink composition and doctoring structure | 惠普印迪戈股份公司 | 2021-10-19 | — | — | CN | disclosed |
| US-11112717-B2 | Electrostatic ink compositions and scratch-off structures | HP INDIGO B.V. (NL) | 2021-09-07 | — | — | US | disclosed |
| EP-3448940-B1 | ELECTROSTATIC INK COMPOSITIONS AND SCRATCH-OFF STRUCTURES | HP INDIGO BV (NL) | 2021-06-02 | — | — | EP | disclosed |
| US-20200393776-A1 | ELECTROSTATIC OVERCOAT COMPOSITION | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2020-12-17 | — | — | US | disclosed |
| US-20200331968-A1 | CYCLIC PEPTIDE ANTIBIOTICS | GENENTECH, INC. (US) | 2020-10-22 | — | — | US | disclosed |
| US-20180072937-A1 | ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE | THE LUBRIZOL CORPORATION | 2018-03-15 | — | — | US | disclosed |
| EP-3283596-A1 | ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE | The Lubrizol Corporation (US) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016168177-A1 | ADDITIVE COMPOSITIONS FOR DRILLING FLUIDS AND METHODS FOR THEIR USE | THE LUBRIZOL CORPORATION (US) | 2016-10-20 | — | — | WO | disclosed |
| WO-2016019216-A1 | ADDITIVE COMPOSITION FOR WELL TREATMENT FLUIDS AND METHODS FOR THEIR USE | THE LUBRIZOL CORPORATION (US) | 2016-02-04 | — | — | WO | disclosed |
| EP-0802254-B1 | Refrigerator oil composition | IDEMITSU KOSAN CO (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-6008169-A | Refrigerator oil composition comprising saturated hydroxy fatty acids and derivatives thereof | IDEMITSU KOSAN CO., LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0802254-A1 | Refrigerator oil composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1997-10-22 | — | — | EP | disclosed |
| EP-0349047-A2 | Treatment of diabetic ketoacidosis | MERCK & CO. INC. (US) | 1990-01-03 | — | — | EP | disclosed |
| EP-0293132-A1 | Antihypercholesterolemic beta-lactones | MERCK & CO. INC. (US) | 1988-11-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331968-A1 | CYCLIC PEPTIDE ANTIBIOTICS | NPPA, LNPEP, CLPP | GPR84 2132/4885FFAR1 3214/4885SPHK1 2893/4885 |
| US-11279735-B2 | Cyclic peptide antibiotics | NPPA, LNPEP, CLPP | GPR84 2132/4885FFAR1 3214/4885SPHK1 2893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.